Amazing result guys and girls! Richard and co are on a roll with their technology platform - each indication further de-risks and cements my investment thesis here. All of this keeps adding to the underlying intrinsic value on offer, great to see highly reputable organisations wanting to work with Richard and his team, I think PIQ is becoming more and more reputable as a gold standard proteomics company here in Australia and now competing on the global front too.
PIQ is a long end game but my god..when (and if) they can start commercialising any one of these - holders will be rewarded for their patience and support.
Note, we need to keep an eye on DotEndo EMPOWER study - they will be presenting their clinical results ~Sept this year. Looking forward to seeing the difference in performance between the two tests.
As most of you know I recently sold 50% of my position due to concerns with the PD roll-out, I am waiting to hear the news on the US progress with FDA and distribution for LDT access. If it looks positive, I will be adding once again.
Happy Thursday folks & congrats to all!
PIQ Price at posting:
81.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)